Shinichi Koizumi
Director/Miembro de la Junta en TSUBOTA LABORATORY INCORPORATED .
Cargos activos de Shinichi Koizumi
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| TSUBOTA LABORATORY INCORPORATED | Director/Miembro de la Junta | 01/06/2020 | - |
| Independent Dir/Board Member | 01/06/2020 | - | |
AskAt, Inc.
 AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | Director/Miembro de la Junta | 01/01/2013 | - |
| Director Técnico/Científico/I+D | 01/01/2013 | - | |
| Corporate Officer/Principal | 01/01/2013 | - |
Historial de carrera de Shinichi Koizumi
Antiguos cargos conocidos de Shinichi Koizumi.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| RAQUALIA PHARMA INC. | Director/Miembro de la Junta | 14/07/2011 | 01/08/2014 |
| Director Técnico/Científico/I+D | 14/07/2011 | 29/11/2012 | |
| Corporate Officer/Principal | - | - |
Formación de Shinichi Koizumi.
| Tokyo Institute of Technology | Doctorate Degree |
Estadísticas
Internacional
| Japón | 5 |
Operativa
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| RAQUALIA PHARMA INC. | Health Technology |
| TSUBOTA LABORATORY INCORPORATED | Commercial Services |
| Empresas privadas | 1 |
|---|---|
AskAt, Inc.
AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | Health Technology |
- Bolsa de valores
- Insiders
- Shinichi Koizumi
- Experiencia
